Skip to content

Author

Aleena Kuriakose

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Bispecific Antibodies Targeting PD-1/PD-L1 and VEGF in Non-Small Cell Lung Cancer

Mature randomized survival data, longer-term safety assessment, and biomarker development are needed to define optimal patient selection and the clinical role of PD-(L)1/VEGF bispecific antibodies in NSCLC.

Aleena Kuriakose, Salem Gogah, E. Beleva · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.